Pediatric Behcet's disease - clinical aspects and current concepts

被引:33
作者
Yildiz, Mehmet [1 ]
Koker, Oya [2 ]
Adrovic, Amra [1 ]
Sahin, Sezgin [1 ]
Barut, Kenan [1 ]
Kasapcopur, Ozgur [1 ]
机构
[1] Istanbul Univ Cerrahpasa, Dept Pediat Rheumatol, Cerrahpasa Sch Med, Istanbul, Turkey
[2] Istanbul Univ, Dept Pediat Rheumatol, Istanbul Sch Med, Istanbul, Turkey
关键词
Behcet's disease; epidemiology; classification; treatment; pediatric; juvenile; GENOME-WIDE ASSOCIATION; REGULATORY T-CELLS; ORAL ULCER; CLASSIFICATION CRITERIA; SUSCEPTIBILITY LOCI; OUTCOME SURVEY; UVEITIS; MANIFESTATIONS; PREVALENCE; FEATURES;
D O I
10.5152/eurjrheum.2019.19121
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Behcet's Disease was first described by a Turkish dermatologist, Hulusi Behcet, in 1937 as a triple symptom complex; aphthous stomatitis, genital ulcers, and uveitis. Today, in light of current trials and experiments, we know that the disease may have a wider involvement with a multisystemic recurrent course, causing significant morbidity and mortality. However, there are still unanswered questions, particularly about Pediatric Behcet's Disease. Although several immunological and genetic associations have been demonstrated, the real etiologic mechanism of the disease is unclear. The diagnosis is difficult due to its rarity in childhood, the lack of validation of the diagnostic criteria obtained from adult studies, and the inadequacy of large case-controlled studies. Also, the management is challenging and controversial due to the various geographic distribution of clinical spectrum. New therapeutic options under development in light of pathogenetic hypothesis seem to be promising.
引用
收藏
页码:S38 / S47
页数:10
相关论文
共 126 条
[1]   Ocular Behcet's Disease: Changing Patterns Over Time, Complications and Long-Term Visual Prognosis [J].
Accorinti, Massimo ;
Pesci, Francesca Romana ;
Pirraglia, Maria Pia ;
Abicca, Irene ;
Pivetti-Pezzi, Paola .
OCULAR IMMUNOLOGY AND INFLAMMATION, 2017, 25 (01) :29-36
[2]   Update on the epidemiology, risk factors and disease outcomes of Behcet's disease [J].
Akkoc, Nurullah .
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2018, 32 (02) :261-270
[3]   Clinical patterns of neurological involvement in Behcet's disease:: evaluation of 200 patients [J].
Akman-Demir, G ;
Serdaroglu, P ;
Tasçi, B .
BRAIN, 1999, 122 :2171-2181
[4]   Epigenetic alterations in chronic disease focusing on Behcet's disease: Review [J].
Alipour, Shahriar ;
Nouri, Mohammad ;
Sakhinia, Ebrahim ;
Samadi, Nasser ;
Roshanravan, Neda ;
Ghavami, Abed ;
Khabbazi, Alireza .
BIOMEDICINE & PHARMACOTHERAPY, 2017, 91 :526-533
[5]   Clinical features and natural course of Behcet's disease in 661 cases: a multicentre study [J].
Alpsoy, E. ;
Donmez, L. ;
Onder, M. ;
Gunasti, S. ;
Usta, A. ;
Karincaoglu, Y. ;
Kandi, B. ;
Buyukkara, S. ;
Keseroglu, O. ;
Uzun, S. ;
Tursen, U. ;
Seyhan, M. ;
Akman, A. .
BRITISH JOURNAL OF DERMATOLOGY, 2007, 157 (05) :901-906
[6]   Behcet's disease: A comprehensive review with a focus on epidemiology, etiology and clinical features, and management of mucocutaneous lesions [J].
Alpsoy, Erkan .
JOURNAL OF DERMATOLOGY, 2016, 43 (06) :620-632
[7]   Anti-TNF Agents for Behcet's Disease: Analysis of Published Data on 369 Patients [J].
Arida, Aikaterini ;
Fragiadaki, Kalliopi ;
Giavri, Eirini ;
Sfikakis, Petros P. .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2011, 41 (01) :61-70
[8]   Behcet Disease in Children [J].
Atmaca, Leyla ;
Boyvat, Ayse ;
Yalcindag, F. Nilufer ;
Atmaca-Sonmez, Pelin ;
Gurler, Aysel .
OCULAR IMMUNOLOGY AND INFLAMMATION, 2011, 19 (02) :103-107
[9]   Successful long-term triple disease control by ustekinumab in a patient with Behcet's disease, psoriasis and hidradenitis suppurativa [J].
Baerveldt, Ewout M. ;
Kappen, Jasper H. ;
Thio, H. Bing ;
van Laar, Jan A. M. ;
van Hagen, P. Martin ;
Prens, Errol P. .
ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (04) :626-627
[10]  
Batu ED, 2017, CLIN EXP RHEUMATOL, V35, pS119